Announcement on Changing Signatory Certified Public Accountant
Filed with SSE · · 2 pages · Chinese
Jiangsu Yahong Meditech Co., Ltd. on 6ix
Earlier from Jiangsu Yahong Meditech
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Completing Changes in Registered Capital and Obtaining Renewed Business License
- Announcement on Election of Employee Directors for the 2nd Board of Directors and Appointment of Senior Management Members
- Announcement on Voluntary Disclosure of Publication of Relevant Data from the APL-1702 International Multicenter Phase 3 Clinical Trial in the International Journal "Med"
- Announcement on Departure of Company Director and Senior Management Member
Later from Jiangsu Yahong Meditech
- Announcement on Voluntary Disclosure of the Release of APL-1401 Phase Ib Clinical Trial Data at the 19th European Colorectal Congress (ECC)
- Announcement on Voluntary Disclosure of Clinical Trial Applications for APL-2401 Approved by China NMPA
- Announcement on Voluntary Disclosure of Acceptance of APLD-2304 for European Medical Device Registration
- Announcement on Voluntary Disclosure of Completion of 1st Subject Enrollment in Phase 1 Clinical Trial of APL-2401
- Announcement on Using Partial Temporarily Idle Raised Funds for Cash Management
Follow Jiangsu Yahong Meditech into a list and get an email when it puts out news.
Follow Jiangsu Yahong Meditech